Report cover image

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

Published Nov 10, 2023
Length 40 Pages
SKU # KLI18299669

Description

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023


In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. IVD Trends and Market Update: November 2023 by Kalorama Information is the most up-to-date resource on these and other key market trends. Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q3 2023 with a publication date of November 2023.

There are some growing segments in the market that have attracted industry attention. Among these are Point-of-Care, next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, mass spectrometry. Gene testing and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD.

Trends highlighted throughout Q3 2023 include:
  • Multiplex testing is proliferating
  • Continued interest in adopting AI technologies
Kalorama Information maintains its unwavering dedication to examining the IVD market and its dynamically evolving landscape. The company's excellence in market analysis is attributed to the extensive expertise of its authors and the market research firm's resolute commitment to providing the most precise and up-to-date data. In IVD Trends and Market Update: November 2023, you’ll discover out:
  • What’s Driving Growth in the IVD Market in Q3 and the last half of 2023?
  • What Major Trends are Affecting the Market in Q3 and the last half of 2023?
  • How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2023?
  • What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?

Table of Contents

40 Pages
    • IVD Market Demand and Growth
    • Effect of COVID-19 on Market Segments
    • Selected New - Q3 2023 - Core IVD Product Launches, Developments and Trends
    • Selected COVID-19 Developments - Q3 2023
    • Selected Competitive Leader Updates
    • Q3 M&A Activity
    • Abbott Laboratories
    • Becton Dickinson and Co
    • bioMérieux SA
    • Danaher Corporation
    • Hologic, Inc.
    • QuidelOrtho Corporation
    • Roche Diagnostic
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Multiplex Testing
    • Next-Generation Sequencing
    • Artificial Intelligence Future Trends
    • Disruptive Technologies
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.